- Home
- VANI vs APLT Comparison
VANI vs APLT Comparison
Compare VANI & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- APLT
- Stock Information
- Founded
- VANI 1998
- APLT 2016
- Country
- VANI United States
- APLT United States
- Employees
- VANI N/A
- APLT N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- VANI Health Care
- APLT Health Care
- Exchange
- VANI Nasdaq
- APLT Nasdaq
- Market Cap
- VANI 75.8M
- APLT 63.6M
- IPO Year
- VANI 2014
- APLT 2019
- Fundamental
- Price
- VANI $1.47
- APLT $0.45
- Analyst Decision
- VANI Strong Buy
- APLT Buy
- Analyst Count
- VANI 1
- APLT 6
- Target Price
- VANI $4.00
- APLT $6.10
- AVG Volume (30 Days)
- VANI 140.9K
- APLT 780.8K
- Earning Date
- VANI 11-12-2025
- APLT 11-06-2025
- Dividend Yield
- VANI N/A
- APLT N/A
- EPS Growth
- VANI N/A
- APLT N/A
- EPS
- VANI N/A
- APLT N/A
- Revenue
- VANI N/A
- APLT $121,000.00
- Revenue This Year
- VANI N/A
- APLT N/A
- Revenue Next Year
- VANI N/A
- APLT $5,931.24
- P/E Ratio
- VANI N/A
- APLT N/A
- Revenue Growth
- VANI N/A
- APLT N/A
- 52 Week Low
- VANI $0.91
- APLT $0.30
- 52 Week High
- VANI $1.80
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- VANI 63.68
- APLT 47.41
- Support Level
- VANI $1.19
- APLT $0.40
- Resistance Level
- VANI $1.55
- APLT $0.46
- Average True Range (ATR)
- VANI 0.10
- APLT 0.03
- MACD
- VANI 0.03
- APLT -0.01
- Stochastic Oscillator
- VANI 80.49
- APLT 33.23
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.